BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9661281)

  • 21. Repeated applications of a transdermal patch: analytical solution and optimal control of the delivery rate.
    Simon L
    Math Biosci; 2007 Oct; 209(2):593-607. PubMed ID: 17490691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new model of resorbable device degradation and drug release: transient 1-dimension diffusional model.
    Perale G; Arosio P; Moscatelli D; Barri V; Müller M; Maccagnan S; Masi M
    J Control Release; 2009 Jun; 136(3):196-205. PubMed ID: 19250952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mathematical model quantifying drug release from lipid implants.
    Siepmann F; Herrmann S; Winter G; Siepmann J
    J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Numerical study of a drug release profile in the transdermal drug delivery system.
    Zeng J; Tikare V; Jacob KI
    Langmuir; 2006 Jan; 22(3):1333-40. PubMed ID: 16430302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro method to characterize diffusion of dye from polymeric particles: a model for drug release.
    Pancholi K; Stride E; Edirisinghe M
    Langmuir; 2009 Sep; 25(17):10007-13. PubMed ID: 19658422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anomalous release of hydrophilic drugs from poly(epsilon-caprolactone) matrices.
    Rosenberg R; Devenney W; Siegel S; Dan N
    Mol Pharm; 2007; 4(6):943-8. PubMed ID: 17960890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higuchi equation: derivation, applications, use and misuse.
    Siepmann J; Peppas NA
    Int J Pharm; 2011 Oct; 418(1):6-12. PubMed ID: 21458553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leaching behaviour of low level organic pollutants contained in cement-based materials: experimental methodology and modelling approach.
    Tiruta-Barna L; Fantozzi-Merle C; de Brauer C; Barna R
    J Hazard Mater; 2006 Nov; 138(2):331-42. PubMed ID: 16949202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding.
    Vaz CM; van Doeveren PF; Dias GR; Reis RL; Cunha AM
    Macromol Biosci; 2004 Aug; 4(8):795-801. PubMed ID: 15468273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mathematical modeling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: polyethylene oxide with high molecular weights.
    Wu N; Wang LS; Tan DC; Moochhala SM; Yang YY
    J Control Release; 2005 Feb; 102(3):569-81. PubMed ID: 15681080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical modeling of simultaneous drug release and in vivo absorption.
    Grassi M; Lamberti G; Cascone S; Grassi G
    Int J Pharm; 2011 Oct; 418(1):130-41. PubMed ID: 21237258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of the release of drugs from transdermal therapeutic systems. Presentation of a new release system].
    Chen LS; Ebel S; Hoffmann U; Osterwald HP
    Arzneimittelforschung; 1989 Nov; 39(11A):1494-7. PubMed ID: 2624596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using PHREEQC for modelling and simulation of dynamic leaching tests and scenarios.
    Tiruta-Barna L
    J Hazard Mater; 2008 Sep; 157(2-3):525-33. PubMed ID: 18295400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model of dissolution-controlled solute release from porous drug delivery polymeric systems.
    Peppas NA
    J Biomed Mater Res; 1983 Nov; 17(6):1079-87. PubMed ID: 6654927
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of colloidal microgels as a (trans)dermal drug delivery system.
    Lopez VC; Hadgraft J; Snowden MJ
    Int J Pharm; 2005 Mar; 292(1-2):137-47. PubMed ID: 15725560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model for drug release from fast phase inverting injectable solutions.
    Raman C; McHugh AJ
    J Control Release; 2005 Jan; 102(1):145-57. PubMed ID: 15653141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.